Comment on“Perihilar cholangiocarcinoma-novel benchmark values for surgical and oncological outcomes from 24 expert centers”  

作　　者：Yasunari Kawabata Yoshitsugu Tajima 

机构地区：[1]Department of Digestive and General Surgery,Shimane University Faculty of Medicine,Izumo,Shimane,Japan

出　　处：《Hepatobiliary Surgery and Nutrition》2022年第2期314-316,共3页肝胆外科与营养（英文）

摘　　要：Perihilar cholangiocarcinoma(PHC)is an aggressive malignancy of the biliary tracts with a dismal outcome.Although the primary goal of surgery for PHC is complete tumor removal with negative resection margins and regional lymphadenectomy,surgery for PHC with curative intent remains a challenge for surgeons because it involves complex surgical procedures such as bile duct resection,major hepatectomy,and/or vascular resection.These intensive procedures are often associated with postoperative complications,including severe morbidity and 30-day mortality with incidences of 40%and 5%,respectively(1).From the perspective of surgical and oncological safety,the standardization of aggressive surgical approaches and the establishment of standardized benchmark values that secure the best achievable outcomes are warranted in the treatment of patients with PHC.

关 键 词：SURGICAL surgery mortality 

分 类 号：R73[医药卫生—肿瘤]